GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a significant focus in healthcare research, largely due to its notable impact on treating diseases such as second type diabetes and obesity. Ongoing trials have revealed that more than glucose regulation, GLP-1 med